Abstract
Breast cancer is poised to become one of the biggest public health concerns in Sub-Saharan Africa by the mid-twenty-first century. Three factors conspire to propel breast cancer to the forefront of disease burden in the region. Firstly, as Sub-Saharan African demographics rapidly come to resemble those of Western societies, rates of the disease are set to surge in the coming decades. Secondly, there is evidence that breast cancer in Sub-Saharan African women is a distinct – and overall more aggressive – disease than that seen in the West, with higher rates of adverse histological and molecular features and poor outcome. Finally, on top of the above, is the irony that the very societies being presented with these challenges are those least able to confront them effectively: with little health infrastructure and poor levels of public health awareness. Here, we provide an overview of the epidemiology, molecular biology and challenges of breast cancer diagnosis and management in Sub-Saharan Africa. This should not, however, be cause for resignation. Examples abound of practical initiatives in Sub-Saharan Africa which have driven monumental improvements in outcomes for breast cancer patients. Furthermore, increasing interest in the biology of this unique disease has already begun to deliver palpable benefits to its sufferers, and has the potential to overcome the challenges which it poses.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdel-Wahab M, Bourque J, Pynda Y, et al. Status of radiotherapy resources in Africa: an International Atomic Energy Agency analysis. Lancet Oncol. 2013;14:e168–e75.
Adebamowo C, Ogundiran T, Adenipekun A, et al. Waist-hip ratio and breast cancer risk in urbanized Nigerian women. Breast Cancer Res. 2002;5:18–24.
Adebamowo C, Famooto A, Ogundiran T, et al. Immunohistochemical and molecular subtypes of breast cancer in Nigeria. Breast Cancer Res Treat. 2008;110:183–8.
Adesunkanmi A, Lawal O, Adelusola K, et al. The severity, outcome and challenges of breast cancer in Nigeria. Breast. 2006;15:399–409.
Akarolo-Anthony S, Ogundiran T, Adebamowo C. Emerging breast cancer epidemic: evidence from Africa. Breast Cancer Res. 2010;12(Suppl 4):S8.
Akosa A, van Norden S, Tettey Y. Hormone receptor expression in male breast cancers. Ghana Med J. 2005;39:14–8.
Bird P, Hill A, Houssami N. Poor hormone receptor expression in East African breast cancer: evidence of a biologically different disease? Ann Surg Oncol. 2008;15:1983–8.
Brinton L, Figueroa J, Awuah B, et al. Breast cancer in sub-Saharan Africa: opportunities for prevention. Breast Cancer Res Treat. 2014;144:467–78.
Chokunonga E, Borok M, Cirenje Z, et al. Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991–2010. Int J Cancer. 2013;133:721–30.
Clegg-Lamptey J, Hodasi W. A study of breast cancer in Korle Bu teaching hospital: assessing the impact of health education. Ghana Med J. 2007;41:72–7.
Clegg-Lamptey J, Dakubo J, Attobra Y. Psychosocial aspects of breast cancer treatment in Accra, Ghana. East Afr Med J. 2009a;86:348–53.
Clegg-Lamptey J, Dakubo J, Attobra Y. Why do breast cancer patients report late or abscond during treatment in Ghana? A pilot study. Ghana Med J. 2009b;43:127–30.
Daramola A, Banjo A, Bennett A, et al. Breast cancer reporting in Lagos, Nigeria: implications for training and education in Africa. J Glob. Oncol. 2016;397–402.
De Ver Dye T, Bogale S, Hobden C, et al. A mixed-method assessment of beliefs and practice around breast cancer in Ethiopia: implications for public health programming and cancer control. Glob Public Health. 2011;6:719–31.
Ellis I, Al-Sam S, Anderson N, et al. Pathology reporting of breast disease in surgical excision specimens incorporating the dataset for histological reporting of breast cancer. London: The Royal College of Pathologists; 2016.
Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase no. 11 [internet]. Lyon: International Agency for Research on Cancer; 2013.
Fregene A, Newman L. Breast cancer in sub-Saharan Africa: how does it relate to breast cancer in African-American women? Cancer. 2005;103:1540–50.
Gakwaya A, Kigula-Mugambe J, Kavuma A, et al. Cancer of the breast: 5-year survival in a tertiary hospital in Uganda. Br J Cancer. 2008;99:63–7.
Galukande M, Wabinga H, Mirembe F, et al. Molecular breast cancer subtypes prevalence in an indigenous sub-Sarahan African population. Pan Afr Med J. 2014;17:249.
Gukas I, Jennings B, Mandong B, et al. Clinicopathological features and molecular markers of breast cancer in Jos, Nigeria. West Afr J Med. 2005;24:209–13.
Hassan I, Onukak E, Mabogunje O. Breast cancer in Zaria, Nigeria. J R Coll Surg Edinb. 1992;37:159–61.
Huo D, Adebamowo C, Ogundiran T, et al. Parity and breastfeeding are protective against breast cancer in Nigerian women. Br J Cancer. 2008;98:992–6.
Huo D, Ikpatt F, Khramtsov A, et al. Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol. 2009;27:4515–21.
Ihemelandu C, Leffall L, Dewitty R, et al. Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival. J Surg Res. 2007;143:109–18.
Ikpatt O, Kuopio T, Collan Y, et al. Proliferation in African breast cancer: biology and prognostication in Nigerian breast cancer material. Mod Pathol. 2002a;15:783–9.
Ikpatt O, Kuopio T, Ndoma-Egba R, et al. Breast cancer in Nigeria and Finland: epidemiological, clinical and histological comparison. Anticancer Res. 2002b;22:3005–12.
Jemal A, Bray F, Forman D, et al. Cancer burden in Africa and opportunities for prevention. Cancer. 2012;118:4372–84.
Jordan I, Hebestreit A, Swai B, et al. Breast cancer risk among women with long-standing lactation and reproductive parameters at low risk level: a case-control study in Northern Tanzania. Breast Cancer Res Treat. 2013;142:133–41.
Kantelhardt E, Mathewos A, Aynalem A, et al. The prevalence of estrogen receptor-negative breast cancer in Ethiopia. BMC Cancer. 2014;14:895.
Kidmas A, Ugwu B, Manasseh A, et al. Male breast malignancy in Jos University Teaching Hospital. West Afr J Med. 2005;24:36–40.
Kingham T, Alatise O, Vanderpuye V, et al. Treatment of cancer in sub-Saharan Africa. Lancet Oncol. 2013;14:e158–67.
McCormack V, Joffe M, van den Berg E, et al. Breast cancer receptor status and stage at diagnosis in over 1200 consecutive public hospital patients in Soweto: South Africa: a case series. Breast Cancer Res. 2013;15:R84.
Okobia M, Bunker C, Okonofua F, et al. Knowledge, attitude and practice of Nigerian women towards breast cancer: a cross-sectional study. World J Surg Oncol. 2006a;4:11.
Okobia M, Bunker C, Zmuda J, et al. Case-control study of risk factors for breast cancer in Nigerian women. Int J Cancer. 2006b;119:2179–85.
Pace L, Shulman L. Breast cancer in sub-Saharan Africa: challenges and opportunities to reduce mortality. Oncologist. 2016;21:739–44.
Pace L, Mpunga T, Hatgekimana V, et al. Delays in breast cancer presentation and diagnosis at two rural cancer referral centres in Rwanda. Oncologist. 2015;20:780–8.
Parkin D, Nambooze S, Wabwire F, et al. Changing cancer incidence in Kampala, Uganda, 1991–2006. Int J Cancer. 2009;126:1187–95.
Perou C, Sørlie T, Eisen M, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747–52.
Phipps A, Chlebowski R, Prentice R, et al. Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst. 2011;203:470–7.
Rambau P, Chalya P, Manyama M, et al. Pathological features of breast cancer seen in northwestern Tanzania: a 9 years retrospective study. BMC Res Notes. 2011;4:214.
Rotimi O, Orah N, Shaaban A, Daramola AO, Abdulkareem FB. Remote teaching in Histopathology using scanned slides via Skype between the United Kingdom and Nigeria. Arch Pathol Lab Med 2017;141:298–300.
Sighoko D, Kamaté B, Traore C, et al. Breast cancer in pre-menopausal women in West Africa: analysis of temporal trends and evaluation of risk factors associated with reproductive life. Breast. 2013;22:828–35.
Speirs V, Shaaban A. The rising incidence of male breast cancer. Breast Cancer Res Treat. 2009;115:429–30.
Stark A, Celina K, Martin I, et al. African ancestry and higher prevalence of triple-negative breast cancer. Cancer. 2010;116:4926–32.
Titloye N, Foster A, Omoniyi-Esan G, et al. Histological features and tissue microarray taxonomy of Nigerian breast cancer reveal predominance of the high-grade triple-negative phenotype. Pathobiology. 2016;83:24–32.
Unger-Saldaña K. Challenges to the early diagnosis and treatment of breast cancer in developing countries. World J Clin Oncol. 2014;5:465–77.
Vorobiof D, Sitas F, Vorobiof G. Breast cancer incidence in South Africa. J Clin Oncol. 2001;19:125s–7s.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Evans, M., Shaaban, A.M. (2017). Breast Cancer in Sub-Saharan Africa. In: Adedeji, O. (eds) Cancer in Sub-Saharan Africa. Springer, Cham. https://doi.org/10.1007/978-3-319-52554-9_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-52554-9_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-52553-2
Online ISBN: 978-3-319-52554-9
eBook Packages: MedicineMedicine (R0)